ORAMED PHARMACEUTICALS INC. (37) | Business Operations (11)
Browse by Subcategory
Recent Contracts
-
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers
(Filed With SEC on May 12, 2022)
-
Clinical Research Organization Services Agreement dated September 16, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC
(Filed With SEC on September 18, 2020)
-
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers
(Filed With SEC on November 24, 2021)
-
Representative Form of Indemnification Agreement between Oramed Pharmaceuticals Inc. and each of its directors and officers
(Filed With SEC on July 14, 2021)
-
Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC
(Filed With SEC on September 9, 2020)
-
Amendment to the Service Agreement, dated January 10, 2020, between KNRY Ltd. and Oramed Ltd
(Filed With SEC on April 6, 2020)
-
Representative Form of Indemnification Agreement between Oramed Pharmaceuticals Inc. and each of our directors and officers
(Filed With SEC on January 9, 2020)
-
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers
(Filed With SEC on November 27, 2019)
-
Amendment #2 to Clinical Research Organization Services Agreement Protocol # ORA-D-015 between Oramed, Inc. and Integrium, LLC
(Filed With SEC on July 10, 2019)
-
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers
(Filed With SEC on July 10, 2019)
-
Amendment #1 to Clinical Research Organization Services Agreement Protocol # ORA-D-015 between Oramed, Inc. and Integrium, LLC
(Filed With SEC on July 10, 2019)